Comparison of Stress and Physiological Variables between Diabetic and Nondiabetic Adults

  • Han, Byung-Jo (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Choi, Seok-Cheol (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Moon, Seong-Min (Department of Clinical Laboratory Science, College of Health Sciences, Catholic University of Pusan) ;
  • Kim, Dae-Sik (Department of Clinical Laboratory Science, Dongnam Health College) ;
  • Hyun, Kyung-Yae (Department of Clinical Laboratory Science, College of Nursing & Healthcare Sciences, Dong-Eui University)
  • Received : 2012.11.03
  • Accepted : 2012.12.04
  • Published : 2012.12.31

Abstract

Diabetes mellitus (DM) is considered to be a serious metabolic disease which may cause systemic complications. The present study was designed to clarify a difference on stress, physiological variables and their correlation between diabetic (DM group) and nondiabetic adults (control group). The levels of body weight, waist circumference, blood pressure, body mass index, body fat mass, total cholesterol (TcH), triglyceride (TG), aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT), total bilirubin (TB), autonomic balance (AB), stress index (SI), fatigue index (FI), and heart rate (HR) were all significantly higher in the DM group than in the control group. However, the levels of autonomic activity (AA), stress resistance (SR), and electrocardiac stability (ES) were significantly lower in the DM group than in the control group. The percentages of persons with abnormal levels in the Tch, high density lipoprotein, low density lipoprotein, TG, AST, ALT and GGT were significantly greater in the DM group than in the control group. In the correlation of glucose and hemoglobin A1c (HBA1c) to stress indices, the DM group had a significant relationship with AB, SR, SI, FI, ES, and HR, whereas the control group had no significant relationship with these, excepting AB. These results suggest that DM was harmfully associated with body, biochemical and stress indices and that blood glucose and HBA1c levels must be exhaustively regulated.

Keywords

References

  1. Akehi Y, Tsutsumi Y, Tatsumoto A, Yoshida R, Ohkubo K, Takenoshita H, Kudo T, Ashida K, Anzai K, Yamashita T, Kawashima H, Ono J, Yanase T. Serum ${\gamma}$-glutamyltransferase, triglyceride and total cholesterol are possible prediabetic risk markers in young Japanese men. Epub J. 2010. 11: 981-989.
  2. Balhara YP, Sagar R. Correlates of anxiety and depression among patients with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2011. 15: S50-S54. https://doi.org/10.4103/2230-8210.83057
  3. Boer-Martins L, Figueiredo VN, Demacq C, Martins LC, Consolin- Colombo F, Figueiredo MJ, Cannavan FP, Moreno H Jr. Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol. 2011. 22: 10-24.
  4. Botton J, Heude B, Andre P, Bresson JL, Ducimetiere P, Charles MA. Relationship between gamma-glutamyltransferase and fat mass in a general population of 8-17 years old children. The FLVS II study. Diabetes Metab. 2007. 5: 354-359.
  5. Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH. Biological basis of depression in adults with diabetes. Curr Diab Rep. 2010. 6: 396-405.
  6. Choi SC, Seok SJ. An association between factor of metabolic syndrome and serum levels of gamma-glutamyl-transpeptidase at age 40 years. J Exp Biomed Sci. 2011. 1: 61-68.
  7. Danese A, Moffitt TE, Harrington H, Milne BJ, Polanczyk G, Pariante CM, Poulton R, Caspi A. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009. 12: 1135-1143.
  8. Fritschi C, Quinn L. Fatigue in patients with diabetes: a review. J Psychosom Res. 2010. 1: 33-41.
  9. Joachim RA, Quarcoo D, Arck PC, Herz U, Renz H, Klapp BF. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom Med. 2003. 5: 811-815.
  10. Lee DH, Jacobs Kr Jt. Gross M. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDI) Study. Clin Chem. 2003. 49: 1358-1366. https://doi.org/10.1373/49.8.1358
  11. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002. 9: 1135-1143.
  12. Martins MC, Faleiro LL, Afonso B, Fonseca A. Association of gamma glutamyltransferase, metabolic syndrome and cardiovascular risk. Acta Med Port. 2010. 4: 579-588.
  13. Naliboff BD, Benton D, Solomon GF, Morley JE, Fahey JL, Bloom ET, Makinodan T, Gilmore SL. Immunological changes in young and old adults during brief laboratory stress. Psychosom Med. 1991. 2: 121-132.
  14. Oda E, Kawai R, Watanabe K, Sukumaran V. Prevalence of metabolic syndrome increases with the increase in blood levels of gamma glutamyltransferase and alanine aminotransferase in Japanese men and women. Intern Med. 2009. 16: 1343-1350.
  15. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. gamma- Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem. 2007. 1: 71-77.
  16. Sen N, Ozlu MF, Basar N, Ozcan F, Gungor O, Turak O, Malcok O, Cagli K, Maden O, Erbay AR, Demir AD. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow. Turk Kardiyol Dern Ars. 2009. 3: 168-173.
  17. Shankar A, Li J. Association between serum gammaglutamyltransferase level and prehypertension among US adults. Circ J. 2007. 10: 1567-1572.
  18. Stranges S, Trevisan M, Dorn JM, Dmocbowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: Evidence from the Western New York Study. Hypertension. 2005. 46: 1186-1193. https://doi.org/10.1161/01.HYP.0000185688.81320.4d
  19. Tovilla-Zarate C, Juarez-Rojop I, Peralta Jimenez Y, Jimenez MA, Vazquez S, Bermudez-Ocana D, Ramon-Frias T, Genis Mendoza AD, Garcia SP, Narvaez LL. Prevalence of anxiety and depression among outpatients with type 2 diabetes in the Mexican population. PLoS One. 2012. 5: 368-387.
  20. Trento M, Raballo M, Trevisan M, Sicuro J, Passera P, Cirio L, Charrier L, Cavallo F, Porta M. A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes. Acta Diabetol. 2011. 3: 199-203.
  21. Vogelzangs N, Suthers K, Ferrucci L, Simonsick EM, Ble A, Schrager M, Bandinelli S, Lauretani F, Giannelli SV, Penninx BW. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology. 2007. 2: 151-159.
  22. von Kanel R, Mills PJ, Fainman C, Dimsdale JE. Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis: a biobehavioral pathway to coronary artery disease? Psychosom Med. 2001. 4: 531-544.
  23. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyl transferase: determinants and association with mortality from ischmic heart disease and all causes. Am J Epidemiol. 1995. 142: 699-708. https://doi.org/10.1093/oxfordjournals.aje.a117699
  24. Whitfield JB. Serum gamma-glutamyltransferase and risk of disease. Clin Chem. 2007. 1: 1-2.
  25. World Health Organization, 2010. http://www.who.int/diabetes/facts/worldfigures/en/.